CORCEPT THERAPEUTICS INC
For the period ended Dec 31, 2023. Filed Feb 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 15, 2024
CORT$75.03+3.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net income | $106,140 | $101,418 | $112,512 |
| Other comprehensive income (loss): | |||
| Unrealized gain (loss) on marketable securities, net of tax impact of $(353), $105, and $198 | 1,120 | (331) | (621) |
| Foreign currency translation gain (loss), net of tax | 358 | (311) | (21) |
| Total comprehensive income | 107,618 | 100,776 | 111,870 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.